{
}
UBS has upgraded Schott Pharma from "Neutral" to "Buy" following positive quarterly results, while reducing the price target from €32.60 to €28.20. Analyst Olivier Calvet anticipates a recovery for the pharmaceutical packaging manufacturer by mid-year.
UBS has maintained a "Neutral" rating for Schott Pharma, setting a target price of €32.60 following the Q1 2024/25 results, which showed EBIT and earnings per share falling 5% and 7% below consensus estimates, respectively. Despite this, the company's shares remain favored by short sellers.
Adar Poonawalla-led Serum Institute has finalized a deal to sell a 30%-40% stake in SCHOTT Poonawalla to TPG Growth, valuing the joint venture at approximately $800 million. SCHOTT Poonawalla, a 50:50 partnership with SCHOTT Pharma AG, specializes in primary glass packaging for the pharmaceutical and biotech industries. The transaction is pending a few formalities.
The healthcare packaging market is segmented by material, product type, packaging type, and application, with plastics leading due to their versatility and barrier properties. Rigid packaging dominates for its strength and safety features, while pharmaceuticals represent the largest application segment, driven by regulatory demands and market growth. North America holds the largest market share, followed by Europe and Asia Pacific, with key players like Amcor and Gerresheimer focusing on innovation and expansion.
Adar Poonawalla-led Serum Institute of India is in advanced talks with TPG to sell a 40% stake in SCHOTT Poonawalla, a joint venture focused on primary glass packaging for the pharma and biotech sectors. The discussions aim to unlock value from Serum's investment made over three years ago, though a final agreement is not guaranteed.
SCHOTT AG
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs upgrades schott pharma to buy lowers price target to 28.20 euros
23:34 24.02.2025
UBS maintains neutral rating for Schott Pharma with target price of 32.60 euros
08:00 13.02.2025
Serum Institute sells stake in Schott Poonawalla to TPG Growth
15:43 28.11.2024
Global Healthcare Packaging Market Sees Rapid Growth and Innovation Opportunities
SCHOTT AG
3M Company
Graphic Packaging International LLC
Huhtamäki Oyj
Berry Global Group, Inc.
West Pharmaceutical Services, Inc.
CCL Industries Inc.
Ardagh Group S.A.
International Paper Co
Westrock Coffee Company
Oliver Healthcare Packaging
SGD Pharma
Gerresheimer AG
Amcor plc
AptarGroup, Inc.
Show more
09:00 11.11.2024
Serum Institute in advanced talks to sell stake in SCHOTT Poonawalla
Serum Institute of India Ltd.
SCHOTT AG
SCHOTT Pharma AG & Co. KGaA
IND
DEU
SCHOTT Poonawalla
Adar Poonawalla
TPG
Show more
14:30 25.10.2024
Trending
Subcategory
Stock Market Updates
Corporate News
Industry Trends
Banking Regulations
Global Financial Events
Finance Mergers & Acquisitions
Financial Scams and Security
Market Analysis and Predictions
Hedge Funds & Private Equity
Startups & Entrepreneurship
Supply Chain Management
Retail and Consumer Goods
Workplace Trends
Global Trade Developments
CEO Changes
AI Innovations
Government Economic Policies
Government Policies
Cryptocurrency Trends
Funding Rounds & Investments
Countries:
Companies:
JPMorgan Chase & Co.
Barclays PLC
Tesla, Inc.
Bank of America Corporation
NVIDIA Corporation
The Goldman Sachs Group, Inc.
Citigroup Inc.
Geode Capital Management LLC
Google Inc.
Apple Inc.
Morgan Stanley
Wells Fargo & Company
Microsoft Corporation
Credit Suisse Real Estate Fund Siat
Charles Schwab Investment Management Inc.
State Street Corporation
Broadcom Inc.
Banco Santander, S.A.
BNP Paribas SA
UniCredit S.p.A.
Currencies:
United States Dollar
Swiss Franc
Indian Rupee
Euro
British Pound Sterling
United Arab Emirates Dirham
Chinese Yuan
Saudi Riyal
Qatari Riyal
Japanese Yen
Singapore Dollar
Kuwaiti Dinar
Offshore Chinese Yuan
Azerbaijani Manat
New Taiwan Dollar
South Korean Won
People: